Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Validation of a Longitudinal Marker as a Surrogate Using Mediation Analysis and Joint Modeling: Evolution of the PSA as a Surrogate of the Disease‐Free Survival

Biometrical Journal(2025)10.1002/bimj.70064Source: DataRank Database

Validation of a Longitudinal Marker as a Surrogate Using Mediation Analysis and Joint Modeling: Evolution of the PSA as a Surrogate of the Disease‐Free Survival is a research paper published in Biometrical Journal (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.86)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Catherine Legrand ORCID,James J. Dignam,Virginie Rondeau ORCID,Quentin Le Coënt ORCID

Live enrichment

PubMed:40579808 PMC:PMC12205229 OpenAlex:https://openalex.org/W4411743937

Agence Nationale de la Recherche

Grant: 17‐EURE‐0019

National Cancer Institute

Grant: U10 CA180822

Agence Nationale de la Recherche

Grant: 17-EURE-0019

Fédération Wallonie-Bruxelles

Grant: ARC-20/25-107

National Institutes of Health

Grant: 2U10CA180822-06

NRG Oncology - Statistical and Data Management Center

FWCI

2.86

Citation Percentile

0.9%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bimj.70064

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bimj.70064

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/bimj.70064

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/bimj.70064

journalhttps://doi.org/10.1002/bimj.70064

Fields of Study

Advanced Causal Inference TechniquesStatistical Methods in Clinical TrialsHealth Systems, Economic Evaluations, Quality of Life

MeSH Terms

Mediation AnalysisBiometryHumansLongitudinal StudiesMaleProstatic NeoplasmsModels, StatisticalBiomarkersProstate-Specific AntigenDisease-Free Survival

Keywords

Surrogate endpointSurrogate dataProstate cancerClinical endpointTime pointBiomarkerOncologyMedicineClinical trialStatisticsInternal medicineCancerMathematicsBiologyBiomarkersSurrogacyJoint ModelingMediation AnalysisMaleBiometryModels, StatisticalProstatic NeoplasmsProstate-Specific AntigenDisease-Free SurvivalApplications of statistics to biology and medical sciences; meta analysisHumansLongitudinal StudiesResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being